Retraction: Small molecule kaempferol promotes insulin sensitivity and preserved pancreatic β-cell mass in middle-aged obese diabetic mice (Journal of Diabetes Research (2015) 2015 (532984) DOI: 10.1155/2015/532984);Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β -Cell Mass in Middle-Aged Obese Diabetic Mice

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Alkhalidy, Hana ^a   Moore, William ^a   Zhang, Yanling ^a   McMillan, Ryan ^a   Wang, Aihua ^a   Ali, Mostafa ^a   Suh, Kyung Shin ^a   Zhen, Wei ^a   Cheng, Zhiyong ^a   Jia, Zhenquan ^b   Hulver, Matthew ^a   Liu, Dongmin ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; FLAVONOL; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; KAEMPFEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STREPTOZOCIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; KAEMPFEROL DERIVATIVE; LIPID;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY COMPOSITION; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME ACTIVITY; FEEDING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LIPOLYSIS; LONG TERM CARE; MALE; MOUSE; MOUSE MODEL; MUSCLE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; KAEMPFEROLS; LIPIDS; MICE; OBESITY;

EID: 84929630423     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2020/1013482     Document Type: Erratum

References (60)

1. American Diabetes Association, Total Prevalence of Diabetes & Pre-Diabetes, 2012.
2. th edition, 2014.
3. H. King, R. E. Aubert, and W. H. Herman, "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections," Diabetes Care, vol. 21, no. 9, pp. 1414-1431, 1998.
4. D. A. Stoffers, "The development of beta-cell mass: recent progress and potential role of GLP-1," Hormone and Metabolic Research, vol. 36, no. 11-12, pp. 811-821, 2004.
5. C. Tourrel, D. Bailbe, M. Lacorne, M.-J. Meile, M. Kergoat, and B. Portha, "Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model byexpansion of the β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4," Diabetes, vol. 51, no. 5, pp. 1443-1452, 2002.
6. H. Sakuraba, H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, and S. Yagihashi, "Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients," Diabetologia, vol. 45, no. 1, pp. 85-96, 2002.
7. P. Marchetti, S. Del Guerra, L. Marselli et al., "Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5535-5541, 2004.
8. I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel et al., "Molecular control of cell cycle progression in the pancreatic β-cell," Endocrine Reviews, vol. 27, no. 4, pp. 356-370, 2006.
9. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, "β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes," Diabetes, vol. 52, no. 1, pp. 102-110, 2003.
10. B. Rolin, M. O. Larsen, C. F. Gotfredsen et al., "Thelong-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice," American Journal of Physiology - Endocrinology and Metabolism, vol. 283, no. 4, pp. E745-E752, 2002.
11. 2+-NFATc1 signaling, and suppresses bone loss in mice," Bone, vol. 60, pp. 104-111, 2014.
12. Y. Zhang, W. Zhen, P. Maechler, and D. Liu, "Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB," The Journal of Nutritional Biochemistry, vol. 24, no. 4, pp.638-646,2013.
13. R. Zamora-Ros, V. Knaze, I. Romieu et al., "Impact of thearu-bigin on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study," European Journal of Clinical Nutrition, vol. 67, no. 7, pp. 779-782, 2013.
14. M.-L. Ovaskainen, R. Törrönen, J. M. Koponen et al., "Dietary intake and major food sources of polyphenols in Finnish adults," Journal of Nutrition, vol. 138, no. 3, pp. 562-566, 2008.
15. J. M. Calderón-Montaño, E. Burgos-Morón, C. Pérez-Guerrero, and M. López-Lázaro, "A review on the dietary flavonoid kaempferol," Mini-Reviews in Medicinal Chemistry, vol. 11, no. 4, pp. 298-344, 2011.
16. S. H. Häkkinen, S. O. Kärenlampi, I. M. Heinonen, H. M. Mykkänen, and A. R. Törronen, "Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries," Journal of Agricultural and Food Chemistry, vol. 47, no. 6, pp. 2274-2279, 1999.
17. K. S. Suh, E.-M. Choi, M. Kwon et al., "Kaempferol attenuates 2-deoxy-D-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells," Biological and Pharmaceutical Bulletin, vol. 32, no. 4, pp. 746-749, 2009.
18. I. Crespo, M. V. García-Mediavilla, B. Gutiérrez, S. Sánchez-Campos, M. J. Tuñón, and J. González-Gallego, "Acomparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells," British Journal of Nutrition,vol.100,no.5,pp.968-976,2008.
19. W. S. Da-Silva, J. W. Harney, B. W. Kim et al., "The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation," Diabetes, vol. 56, no. 3, pp. 767-776, 2007.
20. Y. Zhang, A. Y. Chen, M. Li, C. Chen, and Q. Yao, "Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells," Journal of Surgical Research, vol. 148, no. 1, pp. 17-23, 2008.
21. I. Mylonis, A. Lakka, A. Tsakalof, and G. Simos, "The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions," Biochemical and Biophysical Research Communications, vol. 398, no. 1, pp. 74-78, 2010.
22. R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout, "β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes," Diabetes, vol. 53, supplement 1, pp. S119-S124, 2004.
23. S. J. L. Bakker, R. G. Ijzerman, T. Teerlink, H. V. Westerhoff, R. O. B. Gans, and R. J. Heine, "Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and β-cell failure?" Atherosclerosis, vol. 148, no. 1, pp. 17-21, 2000.
24. M. A. Lazar, "How obesity causes diabetes: not a tall tale," Science, vol. 307, no. 5708, pp. 373-375, 2005.
25. Z. Fu, W. Zhang, W. Zhen et al., "Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice," Endocrinology, vol. 151, no. 7, pp. 3026-3037, 2010.
26. G. Xu, D. A. Stoffers, J. F. Habener, and S. Bonner-Weir, "Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats," Diabetes, vol. 48, no. 12, pp. 2270-2276, 1999.
27. W. N. Burnette, "'Western Blotting': Electrophoretic transfer of proteins from sodium dodecyl sulfate - polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A," Analytical Biochemistry, vol. 112, no. 2, pp. 195-203, 1981.
28. E. Vermeulen, R. Zamora-Ros, E. J. Duell et al., "Dietary flavonoid intake and esophageal cancer risk in the european prospective investigation into cancer and nutrition cohort," The American Journal of Epidemiology, vol. 178, no. 4, pp. 570-581, 2013.
29. S. A. Aldasouqi, D. J. Solomon, S. A. Bokhari, P. M. Khan, S. Muneera, and V. V. Gossain, "Glycohemoglobin A1c: a promising screening tool in gestational diabetes mellitus," International Journal of Diabetes in Developing Countries, vol. 28, no. 4, pp. 121-124, 2008.
30. R. R. Russell III, R. Bergeron, G. I. Shulman, and L. H. Young, "Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 277, no. 2, part 2, pp. H643-H649, 1999.
31. B. F. Holmes, E. J. Kurth-Kraczek, and W. W. Winder, "Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle," Journal of Applied Physiology, vol. 87, no. 5, pp. 1990-1995, 1999.
32. E. R. Gilbert, Z. Fu, and D. Liu, "Development of a nongenetic mouse model of type 2 diabetes," Experimental Diabetes Research, vol. 2011, Article ID 416254, 12 pages, 2011.
33. Z. Yang, M. Chen, L. B. Fialkow, J. D. Ellett, R. Wu, and J. L. Nadler, "The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice," Pancreas, vol. 26, no. 4, pp. e99-e104, 2003.
34. E. Larger, "Weight gain and insulin treatment," Diabetes and Metabolism, vol. 31, no. 4, part 2, pp. 4S51-4S56, 2005.
35. W. J. Schnedl, S. Ferber, J. H. Johnson, and C. B. Newgard, "STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells," Diabetes, vol. 43, no. 11, pp. 1326-1333, 1994.
36. K. H. Miean and S. Mohamed, "Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants," Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3106-3112, 2001.
37. Y. J. Lee, K. S. Suh, M. C. Choi et al., "Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage," Phytotherapy Research, vol. 24, no. 3, pp. 419-423, 2010.
38. M. Hämäläinen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, "Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages," Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007.
39. R. Olszanecki, B. Bujak-Gizycka, J. Madej et al., "Kaempferol, but not resveratrol inhibits angiotensin converting enzyme," Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 387-392, 2008.
40. M. R. Loizzo, A. Said, R. Tundis et al., "Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae)," Phytotherapy Research, vol. 21, no. 1, pp. 32-36, 2007.
41. S. F. Yu, C. T. Shun, T. M. Chen, and Y. H. Chen, "3-O-beta-D-glucosyl-(1 → 6)-beta-D-glucosyl-kaempferol isolated from Sauropus androgenus reduces body weight gain in Wistar rats," Biological and Pharmaceutical Bulletins, vol. 29, no. 12, pp. 2510-2513, 2006.
42. J. W. Kang, J. H. Kim, K. Song, S. H. Kim, J. H. Yoon, and K. S. Kim, "Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells," Phytotherapy Research, vol. 24, supplement 1, pp. S77-S82, 2010.
43. D. W. Haslam and W. P. T. James, "Obesity," The Lancet, vol. 366, no. 9492, pp. 1197-1209, 2005.
44. J.-P. Bastard, M. Maachi, C. Lagathu et al., "Recent advances in the relationship between obesity, inflammation, and insulin resistance," European Cytokine Network, vol. 17, no. 1, pp. 4-12, 2006.
45. B. Klop, J. W. F. Elte, and M. C. Cabezas, "Dyslipidemia in obesity: mechanisms and potential targets," Nutrients, vol. 5, no. 4, pp. 1218-1240, 2013.
46. Y.-S. Lee, B.-Y. Cha, K. Yamaguchi et al., "Effects of Korean white ginseng extracts on obesity in high-fat diet-induced obese mice," Cytotechnology, vol. 62, no. 4, pp.367-376, 2010.
47. J.-Y. Kim, L. A. Nolte, P. A. Hansen et al., "High-fat dietinduced muscle insulin resistance: relationship to visceral fat mass," American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 279, no. 6, pp. R2057-R2065, 2000.
48. K. E. Trajcevski, H. M. O'Neill, D. C. Wang et al., "Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model," PLoS ONE, vol. 8, no. 8, Article ID e71747, 2013.
49. G. A. Bray, "Medical consequences of obesity," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2583-2589, 2004.
50. S. I. Koo and S. K. Noh, "Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect," Journal of Nutritional Biochemistry, vol. 18, no. 3, pp. 179-183, 2007.
51. C.-H. Wu, M.-C. Lin, H.-C. Wang, M.-Y. Yang, M.-J. Jou, and C.-J. Wang, "Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells," Journal of Food Science, vol. 76, no. 2, pp. T65-T72, 2011.
52. S. Pal, M. Naissides, and J. Mamo, "Polyphenolics and fat absorption," International Journal of Obesity and Related Metabolic Disorders, vol. 28, pp. 324-326, 2004.
53. B. B. Zhang, G. Zhou, and C. Li, "AMPK: an emerging drug target for diabetes and the metabolic syndrome," Cell Metabolism, vol. 9, no. 5, pp. 407-416, 2009.
54. G. R. Steinberg and B. E. Kemp, "AMPK in health and disease," Physiological Reviews,vol.89,no.3,pp.1025-1078,2009.
55. R. Bergeron, S. F. Previs, G. W. Cline et al., "Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats," Diabetes, vol. 50, no. 5, pp. 1076-1082, 2001.
56. S. B. Jørgensen, J. F. P. Wojtaszewski, B. Viollet et al., "Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle," FASEB Journal, vol. 19, no. 9, pp. 1146-1148, 2005.
57. M. P. Corcoran, S. Lamon-Fava, and R. A. Fielding, "Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise," The American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 662-677, 2007.
58. G. Perdomo, S. R. Commerford, A.-M. T. Richard et al., "Increased β-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acidinduced insulin resistance despite intramyocellular lipid accumulation," The Journal of Biological Chemistry, vol. 279, no. 26, pp. 27177-27186, 2004.
59. L. Zhang, W. Keung, V. Samokhvalov, W. Wang, and G. D. Lopaschuk, "Role of fatty acid uptake and fatty acid β-oxidation in mediating insulin resistance in heart and skeletal muscle," Biochimica et Biophysica Acta, vol. 1801, no. 1, pp. 1-22, 2010.
60. Y. Zhang and D. Liu, "Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function," European Journal of Pharmacology, vol. 670, no. 1, pp. 325-332, 2011.